Dr. Josh Salvi is a psychiatrist at the MGH Center for OCD and Related Disorders, an Associate Program Director of the MGH/McLean Psychiatry Residency Program, Director of the Physician Scientist Training Program (PSTP) in Psychiatry, and an Investigator at the MGH Translational Research Center. Dr. Salvi also teaches medical students in multiple capacities at Harvard Medical School. Dr. Salvi earned his Ph.D. in Neuroscience from The Rockefeller University in the Laboratory of Sensory Neuroscience with A. James Hudspeth. He graduated from Weill Cornell Medical College and has received various awards, including the Gold Humanism Honor Society’s Humanism in Medicine Award, the John Metcalf Polk Prize for academic achievement in medical school, the American Psychiatric Association’s Leadership Fellowship, the NIMH Outstanding Resident Award Program, the Broad Institute’s Pamela Sklar Fellowship for psychiatric research. He has a research interest in behavioral and genetic studies in OCD and is thrilled to continue clinical work in the same area.
Professional Staff
Natasha Bailen, Ph.D.
Natasha Bailen, Ph.D., is a staff psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital and Harvard Medical School. Dr. Bailen received her PhD in clinical psychology from Washington University in St. Louis, and completed her clinical internship at University of Chicago Medicine. She completed her postdoctoral training at Boston University’s Center for Anxiety and Related Disorders (CARD). She is a licensed clinical psychologist in the state of Massachusetts and specializes in the cognitive-behavioral treatment of OCD, anxiety, and related disorders. Her research focuses on the role of dysregulated emotional processes in psychopathology.
Emily Bernstein, Ph.D.
Emily Bernstein, PhD is a member of the faculty at Harvard Medical School (HMS) and a staff psychologist in the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH). Dr. Bernstein received her bachelor’s degree from Yale University and her PhD in clinical psychology from Harvard University. She completed her clinical internship at VA Boston Healthcare System and postdoctoral training at MGH/HMS and is a licensed psychologist in the state of Massachusetts. Dr. Bernstein’s research is focused on developing alternative and more scalable approaches for the prevention and treatment of OCD and related disorders, anxiety disorders, depression, and other emotional concerns. This includes exploring exercise and other lifestyle interventions and brief cognitive behavioral treatments, as well as leveraging digital tools to bring evidence-based therapy to more people. In this pursuit, she also aims to understand why psychological interventions work, and particularly transdiagnostic ones (or those targeting processes that cut across emotional disorders, like perseverative negative thinking), and to use these insights to increase the efficiency and impact of treatments. Dr. Bernstein was a 2022 recipient of the Anxiety and Depression Association of America (ADAA) Alies Muskin Career Development Leadership Program Award and member of the Career Development Institute for Psychiatry.
Ivar Snorrason, Ph.D.
Ivar Snorrason, Ph.D., is a staff psychologist at the Center for OCD and Related Disorders (CORD) at Massachusetts General Hospital (MGH) and an Instructor in Psychology (Psychiatry) at Harvard Medical School (HMS). Dr. Snorrason completed his bachelor and master’s degrees in psychology at the University of Iceland, and a Ph.D. in clinical psychology at the University of Wisconsin-Milwaukee.
Dr. Snorrason completed post-doctoral training at the New York State Psychiatric Institute/Columbia University Medical School and at McLean Hospital. He is a licensed clinical psychologist and specializes in the treatment of OCD and related disorders. His research focuses on the etiology, nosology and treatment of obsessive-compulsive and related disorders, including trichotillomania (hair-pulling disorder) and excoriation (skin-picking) disorder.
Jeremiah M. Scharf, MD, PhD
Dr. Scharf is a behavioral neurologist and neuropsychiatric geneticist who works at the interface between neurology and psychiatry, employing statistical and molecular genetics techniques along with clinical research tools to investigate the etiology and pathogenesis of Tourette Syndrome (TS), OCD and related disorders as model neuropsychiatric illnesses. Clinically, Dr. Scharf directs the Neurology Tic Disorders Unit within the MGH Division of Movement Disorders, and is Co-Director of the MGH TAA National TS Center of Excellence in partnership with Dr. Sabine Wilhelm in MGH Psychiatry.
